中药调控Nrf2信号通路治疗肝纤维化研究进展OA
Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis:A Review
肝纤维化(HF)是慢性肝损伤后出现的异常修复过程,其发病特征是肝脏细胞外基质的过度积累,造成纤维组织增生,进一步可能发展为肝硬化甚至肝癌.目前临床缺乏特效抗肝纤维化治疗药物,而中医药治疗肝纤维化具有多成分、多靶点干预、安全性高的优势,能显著延缓肝纤维化疾病进展,现已成为当下研究热点.核因子E2相关因子2(Nrf2)作为抗氧化应激的关键转录因子,可通过激活下游抗氧化酶和解毒基因的表达,有效干预肝纤维化进程.该文系统综述了中药有效成分(如黄酮类、多糖类、皂苷类等)及中药复方(如蒿鳖养阴软坚方、鳖甲消癥丸等)通过激活Nrf2信号通路发挥抗纤维化作用的机制,包括增强抗氧化能力、抑制炎症反应、减少肝细胞凋亡、改善线粒体功能及抑制铁死亡途径等方面.此外,该文指出了当前基于Nrf2信号通路研究存在的不足之处,并提出相应建议,旨在促进相关研究,同时也为开发基于Nrf2靶点的新型抗肝纤维化中药提供了重要理论依据.
Hepatic fibrosis(HF)is an abnormal repair process that occurs after chronic liver injury.It is characterized by excessive accumulation of extracellular matrix in the liver,resulting in fibrous tissue hyperplasia,which may further develop into cirrhosis and even liver cancer.Currently,there is a lack of specific anti-HF drugs in clinical practice.Traditional Chinese medicine(TCM)has advantages in the treatment of HF,including multi-component and multi-target interventions with high safety,and can significantly delay the progression of HF.It has therefore become a current research hotspot.Nuclear factor erythroid 2-related factor 2(Nrf2),as a key transcription factor involved in antioxidant stress,can effectively intervene in the progression of HF by activating the expression of downstream antioxidant enzymes and detoxification genes.This article systematically reviews the mechanisms by which active components of Chinese medicine(such as flavonoids,polysaccharides,and saponins)and TCM compound prescriptions(such as Haobie Yangyin Ruanjian prescription and Biejia Xiaozheng pills)exert anti-fibrotic effects through activation of the Nrf2 signaling pathway,including enhancing antioxidant capacity,inhibiting inflammatory responses,reducing hepatocyte apoptosis,improving mitochondrial function,and inhibiting the ferroptosis pathway.In addition,this article points out the current shortcomings in research based on the Nrf2 signaling pathway and proposes corresponding suggestions to promote related studies.It also provides an important theoretical basis for the development of novel anti-HF Chinese medicine targeting Nrf2.
邱树旋;郭琳;王瑞颖;马旭东;苗明三
河南中医药大学 中医药科学院 豫药全产业链研发河南省协同创新中心,郑州 450046||河南省中医药研究院 中药精油研究所,郑州 450046河南省中医药研究院 中药精油研究所,郑州 450046||河南中医药大学 药学院,郑州 450046河南省中医药研究院 中药精油研究所,郑州 450046||河南中医药大学 药学院,郑州 450046河南中医药大学 药学院,郑州 450046河南中医药大学 中医药科学院 豫药全产业链研发河南省协同创新中心,郑州 450046||河南省中医药研究院 中药精油研究所,郑州 450046||河南中医药大学 药学院,郑州 450046
医药卫生
核因子E2相关因子2(Nrf2)肝纤维化中医药抗氧化应激抗炎
nuclear factor erythroid 2-related factor 2(Nrf2)hepatic fibrosistraditional Chinese medicineantioxidant stressanti-inflammatory
《中国实验方剂学杂志》 2026 (9)
276-283,8
国家自然科学基金面上项目(82274119)河南重大科技专项(221100310500)河南省重点研发专项(251111310400,241111311500)河南省中医药科学研究重大专项(2024ZYZD15)河南省"双一流"创建学科中医学科学研究专项(HSRP-DFCTCM-2023-8-09)河南省重大公益专项(201300310100)
评论